Aims/hypothesis

Type 2 diabetes mellitus is associated with moderate decrements in cognitive functioning, mainly in verbal memory, information-processing speed and executive functions. How this cognitive profile evolves over time is uncertain. The present study aims to provide detailed information on the evolution of cognitive decrements in type 2 diabetes over time.

Methods

Sixty-eight patients with type 2 diabetes and 38 controls matched for age, sex and estimated IQ performed an elaborate neuropsychological examination in 2002-2004 and again in 2006-2008, including 11 tasks covering five cognitive domains. Vascular and metabolic determinants were recorded. Data were analysed with repeated measures analysis of variance, including main effects for group, time and the group x time interaction.

Results

Patients with type 2 diabetes showed moderate decrements in information-processing speed (mean difference in z scores [95% CI] -0.37 [-0.69, -0.05]) and attention and executive functions (-0.25 [-0.49, -0.01]) compared with controls at both the baseline and the 4 year follow-up examination. After 4 years both groups showed a decline in abstract reasoning (-0.16 [-0.30, -0.02]) and attention and executive functioning (-0.29 [-0.40, -0.17]), but there was no evidence for accelerated cognitive decline in the patients with type 2 diabetes as compared with controls (all p > 0.05).

Conclusions/interpretation

In non-demented patients with type 2 diabetes, cognitive decrements are moderate in size and cognitive decline over 4 years is largely within the range of what can be viewed in normal ageing. Apparently, diabetes-related cognitive changes develop slowly over a prolonged period of time.

Overview publication

TitleA 4 year follow-up study of cognitive functioning in patients with type 2 diabetes mellitus.
DateJanuary 1st, 2010
Issue nameDiabetologia
Issue numberv53.1:58-65
DOI10.1007/s00125-009-1571-9
PubMed19882137
Authorsvan den Berg E, Reijmer YD, de Bresser J, Kessels RP, Kappelle LJ & Biessels GJ
InfoUtrecht Diabetic Encephalopathy Study Group, van Huffelen AC, de Valk HW, Algra A, Rutten GE, Gispen WH, Algra A, Biessels GJ, Kappelle LJ, Manschot SM, van Gijn J, Reijmer Y, van den Berg E, Brands AM, de Haan EH, Kessels RP, de Bresser J, Jongen C, Mali W, Tiehuis A, van der Grond J, Viergever M
Read Read publication